Gem second batch of company's IPO price finalized

Business News (intern reporter Yu Yuqing) today, the second batch of gem listed 1788.html "> branch issued their respective announcements, confirmed the final http://www.aliyun.com/zixun/aggregation/39391.html" > The issue price, compared with the first batch of 10 companies, the second group of 5 companies that have published their offering prices is much more sensible and has a lower p/e ratio. In accordance with the GEM listing plan, the second batch of 9 companies will start to purchase tomorrow.

As of press time, the second batch of gem has been finalized, the company has 5, the final issue price (and before the issuance of the P/E) is as follows: Net-bed technology (300017) 24 yuan/shares (47.06 times times), China Testing (300012) 25.78 yuan/ Shares (44.45 times times), Ai er Ophthalmology (300015) 28.00 Yuan/shares (45.9 times times), billion-Wei Li (300014) 18 Yuan/shares (40.92 times times), Xinning Logistics (300013) 15.60 yuan/stock (33.91 times times). Not surprisingly, 5 companies have been oversubscribed. 5 companies plan to raise the total of 999 million yuan, the actual raise 2.661 billion yuan, the average over 2.66 times times, of which the most raised is the love of Ophthalmology, was originally planned to raise 340 million yuan, and the actual amount of up to 938 million yuan, to become 5 companies in the circle of money makers.

From the published situation, the second batch of companies in the inquiry interval to determine the issue price, its attitude is more pragmatic, and does not blindly pursue the high price of the high level of financing. It is surprising that, according to the second batch of companies before the inquiry results, xinning logistics and testing to determine the final price of the price is lower than the minimum inquiry, before the two inquiry interval of 18.40-20.24 yuan/shares, 27-32 yuan/share. Of the 5 companies that have been announced, only the Internet technology is issued at a maximum price of 24 yuan. Prior to the completion of the purchase of the first batch of gem companies, in determining the final issue price, half of the enterprises have chosen to the highest inquiry as the final issue price.

Analysts believe that, in principle, listed companies can be in the inquiry range arbitrarily determine the issue price, if the price is too low, the company will probably not raise the full amount of funds required for development, but if the issue is set too high, equivalent to the future of the "overdraft" company, therefore, the listed companies in the determination of the issue price must be based on the actual situation, Careful decision-making. (This source: Beijing Business Newspaper author: Yu Yuqing)